(Worthy News) -Prime Minister Benjamin Netanyahu announced on Friday an agreement to purchase 4 million vaccines from Pfizer as early as January, an agreement that will cost well over $200 million and remains subject to the vaccine receiving approval in the United States.
“This is a great day for the State of Israel, it’s a great day on our road to victory over the coronavirus,” Netanyahu said in a news conference on Friday afternoon.
The announcement was supposed to provide “light at the end of the tunnel” for Israeli who have been living under severe restrictions under two national lockdowns since the spring. [ Source: All Israel News (Read More…) ]
19
people are currently praying.
💡 Did you know? One of the best ways you can support
Worthy News is by simply
leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement —
so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.
(Worthy News) -Prime Minister Benjamin Netanyahu announced on Friday an agreement to purchase 4 million vaccines from Pfizer as early as January, an agreement that will cost well over $200 million and remains subject to the vaccine receiving approval in the United States.